Table 3.

Coefficient of Univariate analysis by cox regression analysis of relapse during observation for patients without anti-allergy therapy.

Variable	Hazard ratio	Lower 95% CI	Upper 95% CI	p value
Past relapse per year, 1 time per year	37.6	2.5	568.5	0.009
Immunosupressant, yes	4.0	1.2	13.2	0.022
Age, 10 years	0.67	0.47	0.97	0.032
Disease duration, 1 year	0.97	0.92	1.02	0.26
Urinary protein, 1 g/gCre	0.28	0.00	37.0	0.61
eGFR, 1 ml/min/1.73 m2	1.01	0.97	1.04	0.81
Minimum PSL dose, 1 mg	1.03	0.84	1.26	0.78
Concomitant allergic disorders, yes	1.08	0.33	3.57	0.89
PSL dose at baseline, 1 mg	1.11	0.95	1.29	0.18
Dyslipedemia, yes	0.54	0.14	2.03	0.36
Hyperurecemia, yes	0.75	0.10	5.87	0.78
Hypertension, yes	1.04	0.32	3.42	0.94
Diabetes mellitus, yes	1.77	0.54	5.81	0.35
Infection, irregular corticosteroid reduction, or malignancy, yes	1.40	0.30	6.46	0.67
IgE, 1 U/mL	1.00	1.00	1.00	0.40
Eos, 1/microg	1.00	1.00	1.00	0.52

Coefficients of univariate Cox regression analysis of relapse during observation in the control group.

Past relapse per year, use of immunosuppressants, and age were statistically associated with relapse.

Cre, creatinine; eGFR, estimated glomerular filtration rate; PSL, prednisolone; CI, confidence interval.